Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$578M |
| 2 |
Micron Technology
MU
|
+$433M |
| 3 |
Advanced Micro Devices
AMD
|
+$404M |
| 4 |
Amazon
AMZN
|
+$398M |
| 5 |
Accenture
ACN
|
+$358M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$777M |
| 2 |
Meta Platforms (Facebook)
META
|
+$752M |
| 3 |
Tesla
TSLA
|
+$627M |
| 4 |
Chevron
CVX
|
+$528M |
| 5 |
Shopify
SHOP
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.4% |
| 2 | Technology | 18.51% |
| 3 | Consumer Staples | 10.15% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Financials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRIN
3226
DELISTED
Marin Software
MRIN
| $289K | ﹤0.01% |
37,617
+329
| +0.9% | +$3.49K |
|
|
NEUE
3227
DELISTED
NeueHealth
NEUE
| $289K | ﹤0.01% |
3,443
-6,804
| -66% | -$903K |
|
|
AFMD
3228
DELISTED
Affimed
AFMD
| $287K | ﹤0.01% |
13,948
-15,249
| -52% | -$424K |
|
3229
Amneal Pharmaceuticals
AMRX
$5.82B
| $287K | ﹤0.01% |
141,900
-30,500
| -18% | -$85.5K |
|
|
IGMS
3230
DELISTED
IGM Biosciences
IGMS
| $287K | ﹤0.01% |
12,600
-22,800
| -64% | -$460K |
|
3231
One Stop Systems
OSS
$330M
| $286K | ﹤0.01% |
89,372
-42,685
| -32% | -$162K |
|
|
STRM
3232
DELISTED
Streamline Health Solutions
STRM
| $286K | ﹤0.01% |
16,018
-793
| -5% | -$17.8K |
|
|
TRVG
3233
trivago
TRVG
$388M
| $286K | ﹤0.01% |
49,233
+5,453
| +12% | +$40.9K |
|
|
BLFY
3234
DELISTED
Blue Foundry Bancorp
BLFY
| $285K | ﹤0.01% |
25,600
-1,300
| -5% | -$15.2K |
|
3235
Bristow Group
VTOL
$1.36B
| $284K | ﹤0.01% |
12,100
-1,200
| -9% | -$31.3K |
|
3236
Bank First Corp
BFC
$1.73B
| $283K | ﹤0.01% |
3,700
-400
| -10% | -$31.2K |
|
3237
FreightCar America
RAIL
$260M
| $283K | ﹤0.01% |
75,835
+33,005
| +77% | +$138K |
|
|
FLNT
3238
Fluent
FLNT
$113M
| $282K | ﹤0.01% |
34,833
-1,967
| -5% | -$16.7K |
|
|
SYRS
3239
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $282K | ﹤0.01% |
43,735
+834
| +2% | +$6.78K |
|
3240
Anixa Biosciences
ANIX
$118M
| $281K | ﹤0.01% |
57,200
-28,682
| -33% | -$116K |
|
3241
OptimumBank Holdings
OPHC
$111M
| $281K | ﹤0.01% |
69,000
-8,963
| -11% | -$35.9K |
|
3242
PTC Therapeutics
PTCT
$5.85B
| $281K | ﹤0.01% |
+5,600
| New | +$274K |
|
|
MTCR
3243
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $281K | ﹤0.01% |
579,536
-9,304
| -2% | -$4.58K |
|
3244
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $280K | ﹤0.01% |
7,000
-10,600
| -60% | -$469K |
|
3245
Coherent
COHR
$67.1B
| $279K | ﹤0.01% |
+8,000
| New | +$383K |
|
3246
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $279K | ﹤0.01% |
2,900
| – | – |
|
3247
Amerant Bancorp
AMTB
$1.15B
| $277K | ﹤0.01% |
11,135
-28,570
| -72% | -$778K |
|
3248
Fidelity High Dividend ETF
FDVV
$10.4B
| $277K | ﹤0.01% |
+8,400
| New | +$312K |
|
|
POL
3249
DELISTED
Polished.com Inc.
POL
| $277K | ﹤0.01% |
10,643
-21,506
| -67% | -$1.04M |
|
3250
KLX Energy Services
KLXE
$46.2M
| $276K | ﹤0.01% |
33,500
+11,400
| +52% | +$68.4K |
|
Similar funds
Renaissance Technologies's Q3 2022 Portfolio in Review
As of Q3 2022, Renaissance Technologies held 4,619 positions worth $70.7B, down 16% from $84.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $8.71B in Q3 2022, closing 637 positions and reducing 2,164 holdings. Its most notable exit was Shopify, an estimated $439M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Alphabet (Google) Class A worth $498M.
- Renaissance Technologies's largest Q3 2022 buy was Alphabet (Google) Class A: 5,208,460 shares worth $498M.
- Renaissance Technologies added most to Advanced Micro Devices in Q3 2022, an estimated $404M increase.
- Renaissance Technologies's biggest Q3 2022 reduction was Apple, cutting an estimated $777M.
- Renaissance Technologies fully exited Shopify in Q3 2022, selling an estimated $439M.
- Renaissance Technologies's ten largest holdings make up 11% of its $70.7B portfolio in Q3 2022.
- Renaissance Technologies opened 441 new positions and closed 637 in Q3 2022.
- Renaissance Technologies's portfolio value fell 16% quarter-over-quarter to $70.7B.
Based on Renaissance Technologies's 13F filing for Q3 2022, filed 14 Nov 2022.